Skip to main content
OpenTrials
Completed

NCT Number: NCT02507726

Multicenter and Open Pilot Clinical Study on the Safety of a New One-piece Convex Appliance in Patients With Enterostomy

This study evaluates the performance of a new 1-piece ostomy convex appliance in patients with enterostomy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Patrick RAT

Dijon, 21000, France

About this study

Primary outcome Measure:

To describe Investigational Device performance in term of level of leakage under the skin protector

Secondary Outcome Measure:

  • Assessment of the condition of peristomal skin
  • Assessment of other performance criteria
  • Assessment of AEs for each patient

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient is at least 18 years old,
  • patient having a colostomy or an ileostomy for at least 1 month,
  • patient having a stoma's diameter inferior to 45 mm,
  • patient having a flat or flushed or slightly retracted stoma,
  • patient using currently a one-piece soft convex or standard ostomy appliance with closed or drainable bags,
  • patient using a minimum of 1 product per day with closed pouches or minimum 1 product per two days with drainable pouches
  • patient capable to apply and remove the pouch himself or with the help of a caregiver (except health care professional)
  • patient having a mental capacity to participate to the study (i.e. to understand the study and to answer to the questions)
  • patient agreeing to test investigational product during 14(±3) days.
  • patient covered by social security

Exclusion criteria

  • patient experiencing repeated leakages with his current appliance,
  • patient receiving or having received, within the last month, chemotherapy or radiotherapy or corticotherapy,
  • patient having a deeply retracted stoma,
  • patient currently suffering from peristomal skin complications (bleeding or severe irritation or red and broken skin at the time of inclusion),
  • patient already participating in another clinical study or who have previously participated in this investigation,
  • pregnant or breast-feeding woman

Treatment and study plan

Flexima Active soft convexe

Device

The Investigational Device will be used during 14 +- 3 days.

Primary outcomes

  1. Flexima® Active Soft Convex ostomy appliance performance description in term of level of leakage under the skin protector

    Time frame: 14 +- 3 days

Secondary outcomes

  1. Peristomal skin evaluation with DET score scale

    Time frame: baseline and 14 +- 3 days

  2. Number of Participants with Adverse Events as a Measure of Safety and Tolerability

    Time frame: baseline and 14 +- 3 days

  3. Investigational product wear time

    Time frame: 14 +- 3 days

    The patient will complete his patient diary after each Investigational Product removal

  4. Investigational product adhesivity as measured by a Likert scale score (1-4)

    Time frame: 14 +- 3 days

  5. Investigational product flexibility as measured by a Likert scale score (1-4)

    Time frame: 14 +- 3 days

  6. Investigational product conformability as measured by a Likert scale score (1-4)

    Time frame: 14 +- 3 days

  7. Convex ring suppleness of the Investigational product as measured by a Likert scale score (1-4)

    Time frame: 14 +- 3 days

  8. Connection of the Investigational Product belt to the belt hear as measured by a Likert scale score (1-4)

    Time frame: 14 +- 3 days

  9. Residues on the skin after each Investigational Product removal as measured by a Likert scale score (1-4)

    Time frame: 14 +- 3 days

  10. Ease of Investigational Product handling as measured by a Likert scale score (1-4)

    Time frame: 14 +- 3 days

  11. Investigational Product wearing comfort as measured by a Likert scale score (1-4)

    Time frame: 14 +- 3 days

  12. Investigational Product leakage prevention as measured by a Likert scale score (1-4)

    Time frame: 14 +- 3 days

  13. Feeling of Investigational Product security as measured by a Likert scale score (1-4)

    Time frame: 14 +- 3 days

  14. Investigational Product overall satisfaction as measured by a Likert scale score (1-4)

    Time frame: 14 +- 3 days

  15. Use of Investigational Product in the future as measured by a Likert scale score (1-2)

    Time frame: 14 +- 3 days

Sponsors and collaborators

Lead sponsor

BBraun Medical SAS

Industry

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Jul 24, 2015
Registry last updated
Sep 23, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.